Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
July-2021 Volume 22 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
July-2021 Volume 22 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Helicobacter pylori infection over bile reflux: No influence on the severity of endoscopic or premalignant gastric lesion development

  • Authors:
    • Andreea Szőke
    • Simona Mocan
    • Anca Negovan
  • View Affiliations / Copyright

    Affiliations: Department of Pathology, Mureș County Clinical Hospital, 540061 Târgu Mureș, Romania, Department of Pathology, Emergency County Hospital, 540136 Târgu Mureș, Romania, Department of Clinical Science‑Internal Medicine, ‘George Emil Palade’ University of Medicine, Pharmacy, Science, and Technology, 540139 Târgu Mureș, Romania
    Copyright: © Szőke et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 766
    |
    Published online on: May 14, 2021
       https://doi.org/10.3892/etm.2021.10198
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Helicobacter (H.) pylori infection and duodenogastric reflux (DGR) are both linked to endoscopic and premalignant gastric lesion development, but it is still unclear whether they are independent or have a causal relationship. This study investigated the histologic gastric changes in patients with primary DGR and H. pylori infection, as well as their endoscopic findings, symptoms, drug consumption, and social behavior in comparison with patients presenting only DGR. The study included 560 patients with primary DGR on endoscopy divided into two groups, according to the presence/absence of H. pylori infection on biopsy (utilizing usual stainings and immunohistochemical methods). There was no significant difference in terms of age and sex, nor in the frequency of diabetes or esophagitis between the studied groups. Epigastric pain was associated with H. pylori‑positive biopsies in multivariate logistic regression analysis (P=0.005). Although without statistical significance, severe endoscopic lesions and premalignant gastric lesions were more frequent in the H. pylori group (45.1 vs. 28.4% and 37.4 vs. 32.3%, respectively). In patients with DGR, the final multivariate model revealed a positive association between smoking and immunohistochemically confirmed H. pylori infection (P=0.02, OR=1.88, 95% confidence intervals (CI)=1.10 to 3.21), but a negative effect of proton pump inhibitor consumption (P<0.001, OR=0.50, 95% CI=0.35 to 0.73). In conclusion, in patients with H. pylori infection and DGR, epigastric pain was the main reason for the endoscopic investigation. H. pylori infection over DGR did not influence the severity of endoscopic or premalignant gastric lesion development. Furthermore, smoking is directly related to immunohistochemically assessed active H. pylori infection in patients with bile reflux.
View Figures

Figure 1

View References

1 

Tatsugami M, Ito M, Tanaka S, Yoshihara M, Matsui H, Haruma K and Chayama K: Bile acid promotes intestinal metaplasia and gastric carcinogenesis. Cancer Epidemiol Biomarkers Prev. 21:2101–2107. 2012.PubMed/NCBI View Article : Google Scholar

2 

Agin M and Kayar Y: The effect of primary duodenogastric bile reflux on the presence and density of Helicobacter pylori and on gastritis in childhood. Medicina (Kaunas). 55(775)2019.PubMed/NCBI View Article : Google Scholar

3 

Chang WK, Lin CK, Chuan DC and Chao YC: Duodenogastric reflux: Proposed new endoscopic classification in sypmtomatic patients. J Med Sci. 36:1–5. 2016.

4 

Amieva M and Peek RM Jr: Pathobiology of Helicobacter pylori-induced gastric cancer. Gastroenterology. 150:64–78. 2016.PubMed/NCBI View Article : Google Scholar

5 

González CA, Sanz-Anquela JM, Gisbert JP and Correa P: Utility of subtyping intestinal metaplasia as marker of gastric cancer risk. A review of the evidence. Int J Cancer. 133:1023–1032. 2013.PubMed/NCBI View Article : Google Scholar

6 

Jencks DS, Adam JD, Borum ML, Koh JM, Stephen S and Doman DB: Overview of current concepts in gastric intestinal metaplasia and gastric cancer. Gastroenterol Hepatol (N Y). 14:92–101. 2018.PubMed/NCBI

7 

Matsuhisa T, Arakawa T, Watanabe T, Tokutomi T, Sakurai K, Okamura S, Chono S, Kamada T, Sugiyama A, Fujimura Y, et al: Relation between bile acid reflux into the stomach and the risk of atrophic gastritis and intestinal metaplasia: A multicenter study of 2283 cases. Dig Endosc. 25:519–525. 2013.PubMed/NCBI View Article : Google Scholar

8 

Asfeldt AM, Steigen SE, Løchen ML, Straume B, Johnsen R, Bernersen B, Florholmen J and Paulssen EJ: The natural course of Helicobacter pylori infection on endoscopic findings in a population during 17 years of follow-up: The Sørreisa gastrointestinal disorder study. Eur J Epidemiol. 24:649–658. 2009.PubMed/NCBI View Article : Google Scholar

9 

Li D, Zhang J, Yao WZ, Zhang DL, Feng CC, He Q, Lv HH, Cao YP, Wang J, Qi Y, et al: The relationship between gastric cancer, its precancerous lesions and bile reflux: A retrospective study. J Dig Dis. 21:222–229. 2020.PubMed/NCBI View Article : Google Scholar

10 

Ladas SD, Katsogridakis J, Malamou H, Giannopoulou H, Kesse-Elia M and Raptis SA: Helicobacter pylori may induce bile reflux: Link between H. pylori and bile induced injury to gastric epithelium. Gut. 38:15–18. 1996.PubMed/NCBI View Article : Google Scholar

11 

Kasi M and Bowling T: Anaemia in gastroenterology. Medicine. 43:153–156. 2015.

12 

Lundell LR, Dent J, Bennet JR, Blum AL, Armstrong D, Galmiche JP, Johnson F, Hongo M, Richter JE, Spechler SJ, et al: Endoscopic assessment of oesophagitis: Clinical and functional correlates and further validation of the Los Angeles classification. Gut. 45:172–180. 1999.PubMed/NCBI View Article : Google Scholar

13 

Lanza FL: Endoscopic studies of gastric and duodenal injury after the use of ibuprofen, aspirin, and other nonsteroidal anti-inflammatory agents. Am J Med. 77:19–24. 1984.PubMed/NCBI View Article : Google Scholar

14 

Capelle LG, de Vries AC, Haringsma J, Ter Borg F, de Vries RA, Bruno MJ, van Dekken H, Meijer J, van Grieken NC and Kuipers EJ: The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. Gastrointest Endosc. 71:1150–1158. 2010.PubMed/NCBI View Article : Google Scholar

15 

McCabe ME IV and Dilly CK: New causes for the old problem of bile reflux gastritis. Clin Gastroenterol Hepatol. 16:1389–1392. 2018.PubMed/NCBI View Article : Google Scholar

16 

Huang H, Tian J, Xu X, Liang Q, Huang X, Lu J and Yao Y: A study on the roles of Helicobacter pylori in bile reflux gastritis and gastric cancer. J BUON. 23:659–664. 2018.PubMed/NCBI

17 

Yu JH, Zheng JB, Qi J, Yang K, Wu YH, Wang K, Wang CB and Sun XJ: Bile acids promote gastric intestinal metaplasia by upregulating CDX2 and MUC2 expression via the FXR/NF-κB signalling pathway. Int J Oncol. 54:879–892. 2019.PubMed/NCBI View Article : Google Scholar

18 

Negovan A, Iancu M, Fülöp E and Bănescu C: Helicobacter pylori and cytokine gene variants as predictors of premalignant gastric lesions. World J Gastroenterol. 25:4105–4124. 2019.PubMed/NCBI View Article : Google Scholar

19 

Pantea M, Negovan A, Banescu C, Bataga S, Neagoe R, Mocan S and Iancu M: Factors associated with recurrent ulcers in patients with gastric surgery after more than 15 years: A cross-sectional single-center study. Gastroenterol Res Pract. 2018(8319481)2018.PubMed/NCBI View Article : Google Scholar

20 

Barakat EAME, Abbas NF and El-Kholi NY: Primary bile reflux gastritis versus Helicobacter pylori gastritis: A comparative study. Egypt J Intern Med. 30:23–27. 2018.

21 

Corojan AL, Dumitrașcu DL, Ciobanca P and Leucuta DC: Prevalence of Helicobacter pylori infection among dyspeptic patients in Northwestern Romania: A decreasing epidemiological trend in the last 30 years. Exp Ther Med. 20:3488–3492. 2020.PubMed/NCBI View Article : Google Scholar

22 

Souza RF, Bayeh L, Spechler SJ, Tambar UK and Bruick RK: A new paradigm for GERD pathogenesis. Not acid injury, but cytokine-mediated inflammation driven by HIF-2α: A potential role for targeting HIF-2α to prevent and treat reflux esophagitis. Curr Opin Pharmacol. 37:93–99. 2017.PubMed/NCBI View Article : Google Scholar

23 

Zhao Y, Li Y, Hu J, Wang X, Ren M, Lu G, Lu X, Zhang D and He S: The effect of Helicobacter pylori eradication in patients with gastroesophageal reflux disease: A meta-analysis of randomized controlled studies. Dig Dis. 38:261–268. 2020.PubMed/NCBI View Article : Google Scholar

24 

Bazin T, Nchare Mfondi A, Julie C, Émile JF, Raymond J and Lamarque D: Contribution of genetic amplification by PCR for the diagnosis of Helicobacter pylori infection in patients receiving proton pump inhibitors. United European Gastroenterol J. 6:1267–1273. 2018.PubMed/NCBI View Article : Google Scholar

25 

Butt J, Varga MG, Wang T, Tsugane S, Shimazu T, Zheng W, Abnet CC, Yoo KY, Park SK, Kim J, et al: Smoking, Helicobacter pylori serology and gastric cancer risk in prospective studies from China, Japan, and Korea. Cancer Prev Res (Phila). 12:667–674. 2019.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Szőke A, Mocan S and Negovan A: <em>Helicobacter pylori</em> infection over bile reflux: No influence on the severity of endoscopic or premalignant gastric lesion development. Exp Ther Med 22: 766, 2021.
APA
Szőke, A., Mocan, S., & Negovan, A. (2021). <em>Helicobacter pylori</em> infection over bile reflux: No influence on the severity of endoscopic or premalignant gastric lesion development. Experimental and Therapeutic Medicine, 22, 766. https://doi.org/10.3892/etm.2021.10198
MLA
Szőke, A., Mocan, S., Negovan, A."<em>Helicobacter pylori</em> infection over bile reflux: No influence on the severity of endoscopic or premalignant gastric lesion development". Experimental and Therapeutic Medicine 22.1 (2021): 766.
Chicago
Szőke, A., Mocan, S., Negovan, A."<em>Helicobacter pylori</em> infection over bile reflux: No influence on the severity of endoscopic or premalignant gastric lesion development". Experimental and Therapeutic Medicine 22, no. 1 (2021): 766. https://doi.org/10.3892/etm.2021.10198
Copy and paste a formatted citation
x
Spandidos Publications style
Szőke A, Mocan S and Negovan A: <em>Helicobacter pylori</em> infection over bile reflux: No influence on the severity of endoscopic or premalignant gastric lesion development. Exp Ther Med 22: 766, 2021.
APA
Szőke, A., Mocan, S., & Negovan, A. (2021). <em>Helicobacter pylori</em> infection over bile reflux: No influence on the severity of endoscopic or premalignant gastric lesion development. Experimental and Therapeutic Medicine, 22, 766. https://doi.org/10.3892/etm.2021.10198
MLA
Szőke, A., Mocan, S., Negovan, A."<em>Helicobacter pylori</em> infection over bile reflux: No influence on the severity of endoscopic or premalignant gastric lesion development". Experimental and Therapeutic Medicine 22.1 (2021): 766.
Chicago
Szőke, A., Mocan, S., Negovan, A."<em>Helicobacter pylori</em> infection over bile reflux: No influence on the severity of endoscopic or premalignant gastric lesion development". Experimental and Therapeutic Medicine 22, no. 1 (2021): 766. https://doi.org/10.3892/etm.2021.10198
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team